Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
UraniumX blickt nach frühem Bohr-Erfolg in eine goldene Zukunft der Atomkraft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.04.EMA's PRIME scheme launches three major new features
14.04.Annovis partners with NeuroRPM on new AI platform to track Parkinson's symptoms
14.04.START partners with Trialing to expand patient access to oncology clinical trials across Europe
13.04.Bristol Myers Squibb evolves and expands multiple myeloma programme
13.04.One-carbon Therapeutics collaborates with Tempus in cancer treatment
10.04.Lilly to acquire Centessa in deal worth up to $7.8bn
10.04.Takeda's CEO-elect, Julie Kim, proposed as new candidate for Board of Directors
09.04.Biogen to acquire Apellis in $5.6bn deal
09.04.Matt Ferriday announced as General Manager for LEO Pharma UK
08.04.Gilead to acquire Tubulis for up to $5bn
08.04.Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development
07.04.Lilly's Foundayo approved by US FDA as oral GLP-1 for weight loss
07.04.Marking World Health Day on 7 April
02.04.Roche opens new Swiss Institute of Human Biology research facility
02.04.ReproNovo appoints Mark Altmeyer as Chairman of the Board
01.04.Novartis to acquire Excellergy in deal worth up to $2bn
01.04.Poolbeg Pharma appoints Adrian Kilcoyne to Scientific Advisory Board
31.03.Pharma's content paradox: why more content is not the answer
31.03.Achieving comms excellence through personalised engagement
31.03.Novo Nordisk's Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes
31.03.Sandoz partners with Samsung Bioepis to develop up to five biosimilars
30.03.The digital age and the advance of AI - pushing communications to new heights
30.03.Merck agrees on $2.2bn deal with Quotient Therapeutics to develop IBD treatment
30.03.Ipsen appoints Michelle Werner as Executive Vice President, President of North America
27.03.Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development